The current stock price of ZYXI is 0.125 USD. In the past month the price decreased by -82.88%. In the past year, price decreased by -98.48%.
ChartMill assigns a fundamental rating of 2 / 10 to ZYXI. ZYXI may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months ZYXI reported a non-GAAP Earnings per Share(EPS) of -1.41. The EPS decreased by -540.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -163.18% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
8 analysts have analysed ZYXI and the average price target is 2.91 USD. This implies a price increase of 2225.6% is expected in the next year compared to the current price of 0.125.
For the next year, analysts expect an EPS growth of -1584.67% and a revenue growth -52.33% for ZYXI
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.3 | 192.719B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.76 | 173.049B | ||
| SYK | STRYKER CORP | 23.7 | 137.017B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 113.066B | ||
| BDX | BECTON DICKINSON AND CO | 14.13 | 59.944B | ||
| IDXX | IDEXX LABORATORIES INC | 43.51 | 51.472B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.47 | 45.675B | ||
| RMD | RESMED INC | 22.12 | 39.65B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.06 | 36.738B | ||
| DXCM | DEXCOM INC | 27.71 | 27.29B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
ZYNEX INC
9655 Maroon Circle
Englewood COLORADO 80112 US
CEO: Thomas Sandgaard
Employees: 1000
Phone: 18004956670
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 1,000 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
The current stock price of ZYXI is 0.125 USD. The price decreased by -34.9% in the last trading session.
ZYXI does not pay a dividend.
ZYXI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
ZYXI stock is listed on the Nasdaq exchange.
The next ex-dividend date for ZYNEX INC (ZYXI) is January 5, 2022.
ZYNEX INC (ZYXI) has a market capitalization of 3.80M USD. This makes ZYXI a Nano Cap stock.